oxycodone extended release tablets 40mg nx "daiichi sankyo" (オキシコドン徐放錠40mgnx「第一三共」)
daiichi sankyo company, limited - oxycodone hydrochloride hydrate - faintly yellowish green tablet, diameter: 8.5mm, thickness: approx. 5.0mm
oxycodone extended release tablets 5mg nx "daiichi sankyo" (オキシコドン徐放錠5mgnx「第一三共」)
daiichi sankyo company, limited - oxycodone hydrochloride hydrate - faint orange tablet, diameter: 7.0mm, thickness: approx. 3.7mm
oxycodone tablets 10mgnx "daiichi sankyo" (オキシコドン錠10mgnx「第一三共」)
daiichi sankyo company, limited - oxycodone hydrochloride hydrate - white tablet, major axis : 8.4mm, minor axis : 4.4mm, thickness : approx. 3.2mm
oxycodone tablets 2.5mgnx "daiichi sankyo" (オキシコドン錠2.5mgnx「第一三共」)
daiichi sankyo company, limited - oxycodone hydrochloride hydrate - light grayish-reddish purple tablet, major axis : 8.4mm, minor axis : 4.4mm, thickness : approx. 3.1mm
oxycodone tablets 20mgnx "daiichi sankyo" (オキシコドン錠20mgnx「第一三共」)
daiichi sankyo company, limited - oxycodone hydrochloride hydrate - pale reddish white tablet, major axis : 10.6mm, minor axis : 5.6mm, thickness : approx. 4.1mm
oxycodone tablets 5mgnx "daiichi sankyo" (オキシコドン錠5mgnx「第一三共」)
daiichi sankyo company, limited - oxycodone hydrochloride hydrate - faint yellow tablet, major axis : 8.4mm, minor axis : 4.4mm, thickness : approx. 3.1mm
adalimumab bs subcutaneous injection 20mg syringe 0.4ml "daiichi sankyo" (アダリムマブbs皮下注20mgシリンジ0.4ml「第一三共」)
daiichi sankyo company, limited - adalimumab (genetical recombination) [adalimumab biosimilar 2] - injection
adalimumab bs subcutaneous injection 40mg pen 0.8ml "daiichi sankyo" (アダリムマブbs皮下注40mgペン0.8ml「第一三共」)
daiichi sankyo company, limited - adalimumab (genetical recombination) [adalimumab biosimilar 2] - injection
adalimumab bs subcutaneous injection 40mg pen 0.8ml "daiichi sankyo" [latex-containing product] (アダリムマブbs皮下注40mgペン0.8ml「第一三共」[ラテックス品])
daiichi sankyo company, limited - adalimumab (genetical recombination) [adalimumab biosimilar 2] - injection
adalimumab bs subcutaneous injection 40mg syringe 0.8ml "daiichi sankyo" (アダリムマブbs皮下注40mgシリンジ0.8ml「第一三共」)
daiichi sankyo company, limited - adalimumab (genetical recombination) [adalimumab biosimilar 2] - injection